Publicacións en colaboración con investigadores/as de Achucarro Basque Center for Neuroscience (11)

2024

  1. Neddylation orchestrates the complex transcriptional and posttranscriptional program that drives Schwann cell myelination

    Science Advances, Vol. 10, Núm. 15

2022

  1. Clemastine Induces an Impairment in Developmental Myelination

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Functional characterization of cannabidiol effect on the serotonergic neurons of the dorsal raphe nucleus in rat brain slices

    Frontiers in Pharmacology, Vol. 13

2021

  1. GABAA receptors expressed in oligodendrocytes cultured from the neonatal rat contain a3 and g1 subunits and present differential functional and pharmacological properties

    Molecular Pharmacology, Vol. 99, Núm. 2, pp. 133-146

2020

  1. Oligodendrocyte Differentiation and Myelination Is Potentiated via GABAB Receptor Activation

    Neuroscience, Vol. 439, pp. 163-180

  2. P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases

    Frontiers in Molecular Neuroscience, Vol. 13

2018

  1. Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis

    Neuropharmacology, Vol. 141, pp. 181-191

2016

  1. Erratum: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling (PLoS Biology (2016) 14:5 (e1002466) DOI: 10.1371/journal.pbio.1002466)

    PLoS Biology

  2. Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling

    PLoS Biology, Vol. 14, Núm. 5

2015

  1. Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo

    GLIA, Vol. 63, Núm. 1, pp. 163-176

2013

  1. Targeting the endocannabinoid system in the treatment of fragile X syndrome

    Nature Medicine, Vol. 19, Núm. 5, pp. 603-607